Lynch & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
4,038
+387
+11% +$109K 0.19% 84
2026
Q1
$974K Buy
3,651
+610
+20% +$169K 0.18% 85
2025
Q4
$837K Sell
3,041
-784
-20% -$220K 0.16% 86
2025
Q3
$1.1M Sell
3,825
-548
-13% -$162K 0.21% 79
2025
Q2
$1.45M Sell
4,373
-2
-0% -$645 0.29% 71
2025
Q1
$1.44M Buy
4,375
+30
+0.7% +$9.04K 0.31% 68
2024
Q4
$1.2M Sell
4,345
-159
-4% -$50.7K 0.26% 71
2024
Q3
$1.56M Buy
4,504
+154
+4% +$53K 0.33% 66
2024
Q2
$1.44M Buy
4,350
+585
+16% +$202K 0.32% 66
2024
Q1
$1.37M Buy
3,765
+412
+12% +$136K 0.32% 66
2023
Q4
$1M Buy
3,353
+1,263
+60% +$369K 0.24% 71
2023
Q3
$598K Buy
+2,090
New +$596K 0.16% 78

Other funds holding CI

Lynch & Associates's CI Position: Q2 2026 in Review

Lynch & Associates increased its Cigna (CI) stake by 11% in Q2 2026, buying an estimated $109K and bringing the position to 4,038 shares worth $1.11M. The position accounts for 0.19% of the portfolio, ranked #84.

Lynch & Associates first reported a position in CI in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.56M in Q3 2024. 256 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Lynch & Associates held 4,038 shares of Cigna worth $1.11M as of Q2 2026.
  • Lynch & Associates bought 387 Cigna shares in Q2 2026, an estimated $109K.
  • Cigna made up 0.19% of Lynch & Associates's portfolio in Q2 2026, its #84 holding.
  • Lynch & Associates first reported a position in Cigna in Q3 2023 and has held it in 12 quarters since.
  • Lynch & Associates's Cigna position peaked at $1.56M in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Lynch & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.